v3.25.1
Revenue (Tables)
3 Months Ended
Mar. 31, 2025
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue [Table Text Block]
The following table represents our revenues disaggregated by product line (in thousands):

Three months ended
March 31,
Product line20252024
Consumables$266,226 $244,039 
Infusion Systems166,300 157,338 
Vital Care172,176 165,278 
Total Revenues$604,702 $566,655 

The following table represents our revenues disaggregated by geography (in thousands):
Three months ended
March 31,
Geography20252024
United States$388,245 $366,155 
Europe, the Middle East and Africa95,688 98,389 
APAC59,411 51,853 
Other Foreign61,358 50,258 
Total Revenues$604,702 $566,655 
Contract with Customer, Asset and Liability [Table Text Block] The following table presents the changes in our contract balances for the three months ended March 31, 2025 and 2024 (in thousands), which is included in accrued liabilities and other long-term liabilities on the condensed consolidated balance sheets:
Contract Liabilities
Beginning balance, January 1, 2025$39,403 
Equipment revenue recognized(15,298)
Equipment revenue deferred due to implementation19,937 
Software revenue recognized(3,077)
Software revenue deferred due to implementation1,201 
Government grant income recognized(1)
(509)
Other deferred revenue recognized(211)
Other deferred revenue 239 
Ending balance, March 31, 2025
$41,685 
Beginning balance, January 1, 2024$42,177 
Equipment revenue recognized(7,499)
Equipment revenue deferred due to implementation9,340 
Software revenue recognized(4,677)
Software revenue deferred due to implementation5,571 
Government grant income recognized(1)
(515)
Other deferred revenue recognized(1,195)
Other deferred revenue155 
Ending balance, March 31, 2024
$43,357 
Deferred Revenue, by Arrangement, Disclosure
As of March 31, 2025, revenue from remaining performance obligations is as follows:

Recognition Timing
(in thousands)< 12 Months> 12 Months
Equipment deferred revenue$20,111 $385 
Software deferred revenue8,646 1,899 
Government grant deferred income(1)
2,064 6,834 
Other deferred revenue(2)
1,664 82 
Total $32,485 $9,200 
_________________________________
(1) The government grant deferred income is amortized over the life of the related depreciable asset as a reduction to depreciation expense.
(2) Other deferred revenue includes pump development programs, purchased training and extended warranty.